ETHYL 4-METHYL-5-OXO-2,5-DIHYDROISOXAZOLE-3-CARBOXYLATE, 95.0%, 250mg

5-Bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-one, 98%, 1g

2-(2-((2,6-Dichlorophenyl)amino)phenyl)acetic acid, 99.00%, 10g

2-Chloroquinoxaline, 97.0%, 25g

4-CHLORO-7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXYLIC ACID, 95.0%, 250mg

Methyl 6-oxo-1,6-dihydropyridine-2-carboxylate, 95.0%, 1g

1-(2-Methoxyphenyl)-N-methylmethanamine, 95.0%, 10g

2,3-Bis(trifluoromethyl)pyridine>95.0%(GC)1g

3-(pyridin-4-yloxy)-8-azabicyclo[3.2.1]octane dihydrochloride, 95.0%, 250mg

4-Pyrrolidin-1-ylmethyl-phenylamine, 95.0%, 1g

4-Methyl-1H-indazol-5-yl-5-boronic acid, 95.0%, 5g

4-(4-Amino-2-fluorophenoxy)pyridin-2-amine, 98%, 100mg

Lanthanum(III) nitrate hexahydrate, min. 99.99%, pa, 250 g, plastic packaging.